Trial Profile
Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy in Reduction of Progression of Atherosclerosis Among Patients With Systemic Lupus Erythematosus: A Randomized Single-Blind Trial
Status:
Recruiting
Phase of Trial:
Phase 0
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- Acronyms pumch-sleas
- 16 Sep 2015 New trial record